Tag: Cancer: Lymphoma
Lymphoma Risk Up With Thiopurine, Anti-TNF Tx in IBD
Risk higher for those exposed to combination therapy versus thiopurine or anti-TNF monotherapy
Calquence Approved for Mantle Cell Lymphoma
For patients who have not responded to at least one prior treatment or who have relapsed
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma
Assay assesses expression of 21 markers, classifies most samples into expected subtype
Gene Tx Approved for Certain Types of B-Cell Lymphoma
First such treatment for certain types of non-Hodgkin lymphoma
PFS Up With Obinutuzumab-Based Tx in Follicular Lymphoma
Induction, maintenance treatment with obinutuzumab-based chemo beats rituximab
FDA Approves Aliqopa for Follicular Lymphoma
Aliqopa, a kinase inhibitor, blocks several enzymes that promote cell growth
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Nephrotic Syndrome Reported With Everolimus, Voriconazole
Case report of patient with relapsed Hodgkin's lymphoma treated with everolimus for five years
Health Care Use Up for Relapse-Free Hodgkin’s Survivors
Rate of outpatient visits, inpatient bed-days up, especially for those requiring multiple chemo courses
HBV, HCV Coinfection Ups Non-Hodgkin Risk in ART-Treated HIV
Increased risk for NHL for HIV-infected patients receiving ART with chronic coinfection with HBV, HCV
